Cite
HARVARD Citation
Cancel, M. et al. (2021). Everolimus or sunitinib as first-line treatment of metastatic papillary renal cell carcinoma: A retrospective study of the GETUG group (Groupe d'Etude des Tumeurs Uro-Génitales). European journal of cancer. pp. 1-11. [Online].